Top Markets
Coin of the day
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
株式のランク #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
株価
$0.84903405
最終同期: 2026-07-27
時価総額
$106.63M
変化(1日)
0.00%
変化(1年)
38.69%
TW
取引 Genovate Biotechnology Co., Ltd. (4130)

カテゴリー

Bの時価総額の4130の価格
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.
4130
$0.84903405
の時価総額 Genovate Biotechnology Co., Ltd.(4130)
時価総額: $106.63M
August 2026時点で、Genovate Biotechnology Co., Ltd. の時価総額は $106.63M です。これは、当社のデータによると、Genovate Biotechnology Co., Ltd. が世界で21465th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Genovate Biotechnology Co., Ltd. の時価総額の履歴(2005 から 2026 まで)
4130最も人気のあるトップ5と比較stocks
4130の価格 資産b bの市場 結果
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.
$41,495.60 $106.63M
$5.211T +4,887,289.01%
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.
$36,203.53 $106.63M
$4.547T +4,263,984.32%
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.
$33,143.77 $106.63M
$4.162T +3,903,603.55%
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.
$28,607.65 $106.63M
$3.593T +3,369,334.45%
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.
$22,238.14 $106.63M
$2.793T +2,619,128.42%